Application of tanshinone IIA or pharmaceutically acceptable salt thereof in improving exercise tolerance of pulmonary vascular disease patients
Patent Information
- Authority / Receiving Office
- CN Ā· China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- THE FIRST AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIV (GUANGZHOU RESPIRATORY CENT)
- Publication Date
- 2013-03-13
- Estimated Expiration
- Not applicable Ā· inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to a new application of tanshinone IIA, in particular to the application of tanshinone IIA or a pharmaceutically acceptable salt thereof in improving activity tolerance of patients with pulmonary vascular diseases. Background technique
[0002] Salvia miltiorrhiza is the dry root and rhizome of Radix Salvia Miltiorrhiza bge., a plant of the Labiatae family. It was first recorded in "Shen Nong's Materia Medica". It is bitter in taste and slightly cold in nature. It is the top grade, Guixin and Liver classics, all of which have been recorded in successive dynasties of herbal medicine.
[0003] Tanshinone ā ” A is an effective monomer extracted from the traditional Chinese medicine Danshen, and its molecular formula is C 19 h 18 o 3 At present, it is mainly used clinically in the treatment of cardiovascular diseases, and has the functions of anti-atherosclerosis, inhibition of left ventricular hypertrophy, and anti-arrhythmi...